In the controversy surrounding the newly developed strains of avian H5N1 flu viruses, scientists and policy makers are struggling with one question in particular: what level of biosafety is best for studying these potentially lethal strains of influenza? In a pair of commentaries, researchers from the Mount Sinai School of Medicine in New York and the University of Michigan arg...
Source: http://www.medicalnewstoday.com/releases/242548.php
Dan Gurney Phil Hill Jim Clark Emerson Fittipaldi
Tidak ada komentar:
Posting Komentar